2381089-83-2

  • Product Name:Retatrutide
  • Molecular Formula:C221H342N46O68
  • Purity:99%
  • Molecular Weight:4731.33
Inquiry

Product Details:

CasNo: 2381089-83-2

Molecular Formula: C221H342N46O68

Appearance: White Powder

Delivery Time: Prompt from stock

Packing: Bottle

Throughput: 10KG/Month

Purity: 99%

linical Trial
NCT Number Sponsor Condition Start Date Phase
NCT05931367 Eli Lilly and Company

Obesity|Overweight|Osteo Arthritis Knee

August 28, 2023 Phase 3
NCT05929066 Eli Lilly and Company

Obesity|Overweight|Knee Pain Chronic|Knee Osteoarthritis|Obstructive Sleep Apnea

August 7, 2023 Phase 3
NCT05882045 Eli Lilly and Company

Obesity|Cardiovascular Diseases

May 30, 2023 Phase 3
NCT05611957 Eli Lilly and Company

Healthy|Renal Insufficiency

November 16, 2022 Phase 1
NCT04881760 Eli Lilly and Company

Obesity|Overweight

May 20, 2021 Phase 2
NCT05445232 Eli Lilly and Company

Obesity

July 8, 2022 Phase 1
NCT04823208 Eli Lilly and Company

Diabetes Mellitus, Type 2

May 24, 2021 Phase 1
NCT05936151 Eli Lilly and Company

Overweight or Obesity|CKD|Type 2 Diabetes

July 20, 2023 Phase 2
NCT06003465 Eli Lilly and Company

Healthy

August 29, 2023 Phase 1
NCT05916560 Eli Lilly and Company

Healthy|Hepatic Insufficiency

July 13, 2023 Phase 1
NCT05929079 Eli Lilly and Company

Type 2 Diabetes|Obesity|Overweight|Obstructive Sleep Apnea

July 11, 2023 Phase 3
NCT05548231 Eli Lilly and Company

Overweight|Obesity

October 24, 2022 Phase 1
NCT04143802 Eli Lilly and Company

Diabetes Mellitus, Type 2

December 18, 2019 Phase 1
NCT05959096 Eli Lilly and Company

Healthy

July 18, 2023 Phase 1
NCT03841630 Eli Lilly and Company

Healthy

March 13, 2019 Phase 1
NCT04867785 Eli Lilly and Company

Type 2 Diabetes

May 13, 2021 Phase 2

Relevant Products